Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

2,700 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Enantioselective desymmetrization of FTY720.
Hikawa H, Hamada M, Uchida Y, Kikkawa S, Yokoyama Y, Azumaya I. Hikawa H, et al. Among authors: uchida y. Chem Pharm Bull (Tokyo). 2014;62(10):1041-4. doi: 10.1248/cpb.c14-00462. Chem Pharm Bull (Tokyo). 2014. PMID: 25273063 Free article.
A case of autoimmune pulmonary alveolar proteinosis responding to oral statin therapy.
Shimamura S, Morikawa H, Shinohara K, Ohkoshi H, Omori C, Hoshino Y, Uchida Y, Masafumi S, Ikemura S, Ohishi N, Kondo T, Soejima K. Shimamura S, et al. Among authors: uchida y. Respir Med Case Rep. 2024 May 25;50:102042. doi: 10.1016/j.rmcr.2024.102042. eCollection 2024. Respir Med Case Rep. 2024. PMID: 38845787 Free PMC article.
Evaluation of microembolic signals on carotid ultrasound during pulmonary vein isolation with high-power short-duration and cryoballoon ablations: When and where do bubble and solid emboli arise?
Mizutani Y, Yanagisawa S, Ichikawa M, Nishio K, Sakai H, Nonokawa D, Makino Y, Suzuki H, Ichimiya H, Uchida Y, Watanabe J, Kanashiro M, Inden Y, Murohara T. Mizutani Y, et al. Among authors: uchida y. J Cardiovasc Electrophysiol. 2024 Jun 4. doi: 10.1111/jce.16337. Online ahead of print. J Cardiovasc Electrophysiol. 2024. PMID: 38837477
Long-term effects of ipragliflozin and pioglitazone on metabolic dysfunction-associated steatotic liver disease in patients with type 2 diabetes: 5 year observational follow-up of a randomized, 24 week, active-controlled trial: Effect of ipragliflozin in MASLD.
Ito D, Shimizu S, Haisa A, Yanagisawa S, Inoue K, Saito D, Sumita T, Yanagisawa M, Uchida Y, Inukai K, Shimada A. Ito D, et al. Among authors: uchida y. J Diabetes Investig. 2024 May 22. doi: 10.1111/jdi.14246. Online ahead of print. J Diabetes Investig. 2024. PMID: 38775319 Free article.
2,700 results